Group | Dog | Lymph node inflammation (score)1 and percentage of dogs from each group with lymphadenomegaly | |||||
---|---|---|---|---|---|---|---|
Basal t1 | % | Postimmunization t2 | % | Acute stage t3 | % | ||
pBCSP | 1 | 0 | 0 | 0 | 50 | 0 | 67 |
2 | 0 | 0 | 0 | ||||
3 | 0 | 0 | 1 | ||||
4 | 0 | 2 | 1 | ||||
5 | 0 | 1 | 1 | ||||
6 | 0 | 1 | 2 | ||||
pBCSSP4 | 1 | 0 | 0 | 0 | 50 | 1 | 100* |
2 | 0 | 1 | 2 | ||||
3 | 0 | 2 | 1 | ||||
4 | 0 | 1 | 1 | ||||
5 | 0 | 0 | 2 | ||||
6 | 0 | 0 | 2 | ||||
pBK-CMV | 1 | 0 | 0 | 0 | 17 | 0 | 83* |
2 | 0 | 0 | 1 | ||||
3 | 0 | 0 | 1 | ||||
4 | 0 | 0 | 2 | ||||
5 | 0 | 1 | 1 | ||||
6 | 0 | 0 | 1 | ||||
SS mock-immunized | 1 | 0 | 0 | 0 | 0 | 1 | 100* |
2 | 0 | 0 | 1 | ||||
3 | 0 | 0 | 1 | ||||
4 | 0 | 0 | 1 | ||||
5 | 0 | 0 | 1 | ||||
6 | 0 | 0 | 1 |